[Chemotherapy for digestive carcinomas. Results of a phase II clinical trial (author's transl)]
- PMID: 95458
[Chemotherapy for digestive carcinomas. Results of a phase II clinical trial (author's transl)]
Abstract
A so-called "phase II" clinical trial was carried out in 89 patients with digestive carcinomas who were treated either by chemotherapy alone or by a combination of surgery and chemotherapy. Thirty-five patients with inoperable tumours received chemotherapy alone without any noticeable improvement. Thirty-two patients had tumours which were operable but with inoperable extension. Palliative chemotherapy, given after surgery to reduce the size of the tumour, resulted in a prolongation of survival. Twenty-two patients with operable tumours without inoperable extension benefited from routine adjuvant chemotherapy.
Similar articles
-
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.Cancer. 2002 Oct 15;95(8):1685-95. doi: 10.1002/cncr.10831. Cancer. 2002. PMID: 12365016 Clinical Trial.
-
Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin.Cancer Treat Rep. 1977 Oct;61(7):1375-7. Cancer Treat Rep. 1977. PMID: 201379 No abstract available.
-
Chemotherapy for gastrointestinal malignancy.Am J Gastroenterol. 1980 Jul;74(1):40-9. Am J Gastroenterol. 1980. PMID: 7424879
-
Infusional 5-fluorouracil in the treatment of gastrointestinal cancers: The Royal Marsden Hospital experience.J Infus Chemother. 1996 Summer;6(3):141-4. J Infus Chemother. 1996. PMID: 9229326 Review. No abstract available.
-
Chemotherapy and cancer of the gastrointestinal tract.Surg Annu. 1979;11:149-80. Surg Annu. 1979. PMID: 388686 Review.